YXYu Xia

Yu Xia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yu Xia has a total of 105 co-authors. Here are the top co-authors by number of shared publications:

  • Luying Gao

    Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    14 shared publications
  • Ruifeng Liu

    Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    12 shared publications
  • Liyuan Ma

    Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    11 shared publications
  • Xinlong Shi

    Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing, Peoples R China

    11 shared publications
  • Xiaoyi Li

    Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    9 shared publications
  • Aonan Pan

    Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    8 shared publications

Latest Publications

  • Could superb microvascular imaging or shear wave elastography tell us the growth record of suspicious thyroid nodules measuring ≤ 10 mm? A retrospective study

    by Xinlong Shi, Ruifeng Liu, Yu Xia, Nengwen Luo, Luying Gao, Liyuan Ma, Jiang Ji, Aonan Pan, Yu’ANg An, Yuxin Jiang

    Purpose Identifying TR5 nodules smaller than 10 mm that have increased in size is an important issue in clinical practice. Our study investigated whether superb microvascular imaging (SMI) and shear wave elastography (SWE) could help identify previous enlargement in ACR TI-RADS 5 (TR5) thyroid nodules measuring ≤ 10 mm. Methods Each nodule underwent ultrasound examination for SMI and SWE. VImax is the largest vascular index between the transverse and longitudinal sections. The SWV ratio is the ratio of thyroid nodules to peripheral glands. The enlargement of thyroid nodules was defined as a growth rate > 2 mm/y or an increase in size of > 3 mm in the largest dimension. Results Of all 51 TR5 TNs, 25 (49.0%) were defined as enlarged nodules. Regarding vascular and elasticity features, enlarged nodules were more likely to present intra-nodular vascularity (80.0% vs. 46.2%, p = 0.03), had higher VImax (21.18 ± 8.31 vs. 15.77 ± 9.96, p = 0.03), and lower mean SWV-ratio (1.27 ± 0.38 vs. 1.66 ± 0.37, p < 0.001) compared with stable nodules. Multivariable logistic regression showed that mean of SWV-ratio (β=−3.35, p = 0.005), initial size (β=−1.06, p = 0.003), and intra-nodular vascularity (β = 1.97, p = 0.049) were independent predictors of nodule growth, whereas VImax was not significant. A logistic regression model incorporating these three variables demonstrated excellent discriminative ability, with an area under the ROC curve of 0.882 (95% CI, 0.786–0.977) based on 2000 bootstrap iterations. Conclusion In our study, intranodular vascularity and a low shear wave velocity ratio may help identify those nodules that have experienced enlargement. Owing to the small sample size and retrospective study design of our study, more prospective studies with large sample sizes should be conducted to study the value of SMI and SWE in managing suspicious thyroid nodules.

  • Open Access

    Improved Preoperative Diagnosis of Medullary Thyroid Carcinoma Using Dual-Mode Ultrasound Radiomics

    by Luying Gao, Naishi Li, Yu Xia, Liyuan Ma, Yuang An, Jiang Ji, Jionghui Gu, Dingyue Zhang, Nengwen Luo, Yang Cao, et al.

    Background: Preoperative diagnosis of medullary thyroid carcinoma (MTC) is clinically challenging due to sonographic overlap with other thyroid tumors. To address this, we aimed to develop a multi-vendor, multimodal radiomic framework for accurate MTC identification, comparing its diagnostic performance with that of experienced radiologists. Methods: This retrospective study included 467 pathologically confirmed thyroid nodules (94 MTCs, 373 non-MTCs) acquired across multiple ultrasound platforms. The dataset was randomly partitioned into training (80%) and internal testing (20%) sets. In total, 2250 radiomic features were extracted from grayscale and color Doppler images, followed by Z-score normalization to mitigate batch effects. A robust feature selection strategy (LASSO and recursive feature elimination) identified optimal signatures for developing machine learning classifiers (SVM, LR, RF). The optimal model was further validated on an independent, balanced cohort (n = 60; comprising 12 cases each of MTC, papillary carcinoma, follicular carcinoma, follicular adenoma, and nodular goiter) and compared with experienced radiologists across seven classification tasks. Results: The RF model achieved an AUC of 0.993 in distinguishing MTC from papillary carcinoma. The LR model showed an AUC of 0.991 for identifying MTC from all other nodules. In the independent validation cohort, the models maintained superior discriminatory ability, showing better diagnostic performance compared to the image interpretation by radiologists (AUC 0.993 vs. 0.488, p < 0.001). Conclusions: The proposed multi-vendor, multimodal radiomic system demonstrated good discriminative ability in the diagnosis and stratification of MTC. By integrating grayscale and Doppler ultrasound features while overcoming scanner variability, this model shows potential as a non-invasive adjunctive tool.


  • Open Access

    A nomogram for malignancy prediction of pancreatic cystic lesions based on trans-abdominal ultrasound features

    by Liyuan Ma, Ya Hu, Yu Xia, Jiang Ji, Jionghui Gu, Nengwen Luo, Aonan Pan, Yang Cao, Yuang An, Luying Gao, et al.

    Background: Pancreatic cystic lesions (PCLs) have variable malignant potential, and distinguishing benign from malignant/premalignant cysts is challenging for optimal management. Trans-abdominal ultrasound (TAUS), a widely available, non-invasive, low-cost first-line pancreatic imaging tool, is underexplored for predicting PCL malignant potential. This study aimed to develop a TAUS feature-based nomogram for this purpose. Methods: This retrospective study included 161 patients with pathology-confirmed PCLs from December 2012 to July 2021, divided into benign (59 cases) and non-benign (premalignant/malignant, 102 cases) groups. Relevant clinical characteristics and TAUS features were collected. Least absolute shrinkage and selection operator (LASSO) logistic regression analysis was used to optimize feature selection. Multivariate logistic regression analysis was applied to construct the nomogram. The performance of the nomogram was assessed via receiver operating characteristic curves, calibration curves and decision curve analysis (DCA). Results: Among the 26 features collected, 11 features were chosen via LASSO analysis. Multivariate analysis identified echogenicity, the configuration of cysts, solid content and septation/wall thickening as independent predictors. The prediction nomogram model developed with these four variables showed moderate discriminative performance in differentiating non-benign from benign PCLs, with an area under the curve (AUC) of 0.781. Regarding internal verification, tenfold cross-validation yielded a C-index of 0.749. The Hosmer–Lemeshow test yielded a P = 0.945, suggesting that the model had a good fit. Additionally, DCA demonstrated good net clinical benefit. Conclusions: This study explored the value of TAUS features for predicting the malignant potential of PCLs. The incorporation of TAUS features into a nomogram may offer a potential non-invasive tool to help clinicians in risk stratification during the initial evaluation and follow-up assessment of PCLs patients.

  • Open Access

    The prognostic value of ultrasound features and parafibromin expression in parathyroid carcinoma

    by Ruifeng Liu, Liyuan Ma, Yu Xia, Luying Gao, Jiang Ji, Yuang An, Aonan Pan, Nengwen Luo, Yuxin Jiang

    Objectives: To investigate prognostic factors related with parathyroid carcinoma (PC) based upon ultrasound (US) parameters and parafibromin expression. Methods: Between 2000/01 and 2022/07, thirty-four PC patients with detailed preoperative ultrasonography were enrolled in the research. Immunohistochemical staining of parafibromin was performed on pathological samples of these patients. Based on the expression of parafibromin, the cases were divided into a positive control group (parafibromin expression ≥ 10%) and a negative experimental group (parafibromin expression < 10%). The ultrasound and clinical features of the two groups were analyzed, and Cox regression was used to identify the independent prognostic factors regarding disease-free survival (DFS) and overall survival (OS). Results: Among 34 patients with parathyroid carcinoma, 26 (76.5%) were parafibromin-positive, while 8 (23.5%) were parafibromin-negative. The mean follow-up time was 72.6 (11.0-179.3) months. During the overall survival period, 7 cases (20.6%) died, and 9 cases (26.5%) experienced recurrence or metastasis. The median overall survival time (interquartile range) was 65.7 (35.5–89.7) months, and the median disease-free survival time (interquartile range) was 38.2 (22.2–69.7) months. The risk of recurrence and metastasis in the parafibromin-negative group was 5.9 times higher than that in parafibromin-positive group (95% CI 1.569–22.190). PC patients with calcification on preoperative ultrasonography had a 9.4 times higher risk of death during the overall survival period compared with patients without calcification (95% CI 1.037–85.915). However, parafibromin expression did not show a significant impact on the prognosis of the overall survival. Conclusions: Preoperative US-detected calcification within the lesion is an independent risk factor indicating the shorter OS for PC patients, while loss of parafibromin expression is significant for indicating the recurrence or metastasis of PC patients.


  • Open Access

    Can cereal-based oral contrast agents-assisted ultrasound become an alternative to non-contrast magnetic resonance imaging (MRI) in radiological follow-up for pancreatic cystic lesions?

    by Jiang Ji, Xinlong Shi, Yu Xia, Luying Gao, Nengwen Luo, Liyuan Ma, Aonan Pan, Yuang An, Ya Hu, Yuxin Jiang

    Background: Pancreatic cystic lesions (PCLs) are recommended to be examined by magnetic resonance imaging (MRI), yet MRI still has limitations, such as high costs, the risk of triggering claustrophobia, and relatively low availability compared with ultrasound. Oral contrast agents-assisted ultrasound has been used to examine the gallbladder and stomach, but whether oral contrast agents could improve the accuracy of transabdominal ultrasound (TAUS) for PCLs and could be a potential alternative to non-contrast MRI for PCL follow-up has not been studied. This study aimed to explore the value of cereal-based oral contrast agents in improving the accuracy of PCLs during TAUS. Methods: This is a prospective cohort study. Patients with PCL who were admitted to our center between January 2023 and January 2024 were enrolled, and TAUS was performed before and after taking cereal-based oral contrast agents. The imaging quality of the PCL was measured by structural visualization scores. The structural visualization scores of oral contrast agent-assisted ultrasound and non-contrast MRI were also compared. Results: A total of 27 patients with PCLs were enrolled, and 30 PCLs were detected. The sonolucency of the PCL improved after oral contrast agent administration. Before taking the agent, only 30% of patients had satisfactory sonolucency; after taking the oral contrast agent, the corresponding proportion reached 80% (P=0.002). The structural visualization score of the PCL determined by oral contrast agent-assisted TAUS was higher than that determined without the aid of an agent [1 (0–6) vs. 1 (0–3), P=0.001], which was mainly reflected in the increase in the number of visible septa after taking the agent. No significant difference was detected between the structural visualization score of the PCL examined by oral contrast agent-assisted TAUS and that examined by non-contrast MRI and the correlation between the 2 types of scores were satisfactory [1 (0–6) vs. 2 (0–7), P=0.070, Spearman correlation factor r=0.880]. Conclusions: This study used a structured scoring system to confirm that cereal-based oral contrast agents could improve the ultrasound quality of PCLs, and the correlation between the quality of oral contrast agent-assisted ultrasound and non-contrast MRI findings on PCLs was satisfactory. Further research to improve visualization of PCLs on TAUS using oral contrast agents could result in TAUS being a potential alternative to MRI in the follow-up of PCLs in resource-limited situations.


  • A Long-Term Study Comparing the Quality of Life and Psychological Status of Patients with Highly Suspicious Thyroid Nodules ≤1 cm Undergoing Active Surveillance with Those Undergoing Immediate Surgery

    by Chun-Hao Liu, Hao Zhao, Ying Lu, Yu Xia, Yue Cao, Li-Yang Zhang, Ya Zhao, Luying Gao, Yuewu Liu, Hongfeng Liu, et al.

    Background: Limited information is available on the long-term impact of active surveillance (AS) and immediate surgery (IS) on the quality of life (QoL) and psychological status of patients with highly suspicious subcentimeter thyroid nodules. Methods: A prospective study was conducted on 752 patients showing highly suspicious subcentimeter thyroid nodules, among whom 584 chose AS and 168 chose IS. All patients underwent at least two assessments regarding their QoL and psychological status, using three questionnaires: Thyroid Cancer-Specific Quality of Life (THYCA-QoL), Hospital Anxiety and Depression Scale (HADS), and European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (QLQ-C30). Propensity-score matching (PSM) at a ratio of 3:1 was utilized on patients in the AS and IS groups to mitigate selection bias (504 patients in the AS group and 168 in the IS group). Subsequently, the mixed linear model was used to analyze the QoL data. Results: The median time from the initial evaluation to the last follow-up in the AS and IS groups was 24.0 and 14.2 months, respectively. The AS group showed superior QoL outcomes compared to the IS group, mainly manifested in voice ( p < 0.001), sympathetic ( p = 0.008), throat/mouth ( p < 0.001), and problems with scar ( p < 0.001) domains, as per the THYCA-QoL questionnaire. Further, the EORTC QLQ-C30 questionnaire highlighted better outcomes in physical function ( p = 0.029), role function ( p < 0.001), social function ( p < 0.001), global health status ( p < 0.001), fatigue ( p = 0.012), pain ( p = 0.028), appetite loss ( p = 0.017), and financial difficulties ( p < 0.001). Compared to the initial assessment (1 week after surgery), the IS group showed progressive improvements in QoL, especially in voice ( p = 0.024), throat/mouth ( p < 0.001), physical function ( p = 0.004), social function ( p = 0.014), nausea and vomiting ( p < 0.001), pain ( p = 0.006), and appetite loss ( p = 0.048) domains as per both questionnaires. Conclusion: Patients with highly suspicious subcentimeter thyroid nodules who choose IS tend to experience a poorer long-term QoL compared to those who choose AS. Although the situation may improve over time, certain issues might persist, making AS a favorable option for these patients.


  • Risk factors for tumor enlargement in low-risk papillary thyroid microcarcinoma patients: a systematic review and meta-analysis

    by Nengwen Luo, Xinlong Shi, Yu Xia, Luying Gao, Xiaoyi Li, Yuxin Jiang

    Purpose The current management guidelines for low-risk papillary thyroid microcarcinoma (PTMC) do not specify how to screen for growing tumors. We sought to explore the possible risk factors for tumor enlargement in patients with low-risk PTMC under active surveillance (AS). Methods We searched the PubMed and Embase databases for high quality studies up to January 10th, 2024. The Newcastle-Ottawa Scale (NOS) was used to assess the quality of the included studies, and Review Manager 5.4 was used to analyze possible risk factors and calculate pooled risk ratios (RRs) via the inverse-variance calculation method. Results Eleven studies were included in our meta-analysis. Among the 8880 participants, 464 experienced tumor growth, and the incidence of tumor growth varied from 3.4% to 19.4%. The results of the meta-analysis showed that tumor enlargement was associated with younger age (pooled RR = 2.32, 95% CI = 1.85–2.90, p < 0.00001; 8 studies), and higher serum thyroid-stimulating hormone (TSH) levels (pooled RR = 2.28, 95% CI = 1.19–4.37, p = 0.01; 6 studies), and could be related to pregnancy (pooled RR = 2.54, 95% CI = 1.17–5.52, p = 0.02; 2 studies). However, these following factors showed no significant association with tumor growth: sex (pooled RR = 1.07, 95% CI = 0.63–1.84, p = 0.79; 7 studies), tumor size at diagnosis (pooled RR = 1.08, 95% CI = 0.63–1.85, p = 0.77; 5 studies), and Hashimoto’s thyroiditis (HT) (pooled RR = 1.56, 95% CI = 0.93–2.60, p = 0.09; 2 studies). Conclusion Our analysis identified that younger age and higher serum TSH levels were higher risk factors for tumor enlargement in low-risk PTMC patients. Pregnancy is a suspected risk factor.


  • BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients

    by Hao Zhao, Chun-Hao Liu, Ying Lu, Shu-Zhou Liu, Palashate Yeerkenbieke, Yue Cao, Yu Xia, Lu-Ying Gao, Yue-Wu Liu, Zi-Wen Liu, et al.